Muse Cells Derived from Dermal Tissues Can Differentiate into Melanocytes

Cellular Reprogramming

Volumn 19, Issue 2, 2017, Pages 116-122

  Tian, Ting ^a   Zhang, Ru Zhi ^a   Yang, Yu Hua ^a   Liu, Qi ^a   Li, Di ^a   Pan, Xiao Ru ^b  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b BENGBU MEDICAL COLLEGE   (China)

Author keywords

Differentiated into melanocyte; Human scalp dermal fibroblasts; Muse cells

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; METHYLCELLULOSE; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 3; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; STAGE SPECIFIC EMBRYO ANTIGEN; STAGE-SPECIFIC EMBRYONIC ANTIGEN-3; TUMOR ANTIGEN;

ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DERMIS; FLOW CYTOMETRY; HAIR FOLLICLE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MELANOCYTE; MULTILINEAGE DIFFERENTIATING STRESS ENDURING CELL; PLURIPOTENT STEM CELL; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCALP; SEBACEOUS GLAND; SKIN FIBROBLAST; STEM CELL SELF-RENEWAL; SWEAT GLAND; WESTERN BLOTTING; CELL CULTURE; CELL LINEAGE; CYTOLOGY; FIBROBLAST; METABOLISM; PHYSIOLOGICAL STRESS;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; DERMIS; FIBROBLASTS; HUMANS; MELANOCYTES; SCALP; STAGE-SPECIFIC EMBRYONIC ANTIGENS; STRESS, PHYSIOLOGICAL;

EID: 85017190512     PISSN: 21524971     EISSN: 21524998     Source Type: Journal    
DOI: 10.1089/cell.2016.0032     Document Type: Article

References (23)

1. Adema, G.J., de Boer, A.J, Vogel, A.M., Loenen, W.A., and Figdor, C.G. (1994). Molecular characterization of the melanocyte lineage-specific antigen gp100. J. Biol. Chem. 269, 20126-20133.
2. Dezawa, M. (2016). Muse cells provide the pluripotency of mesenchymal stem cells: direct contribution of Muse cells to tissue regeneration. Cell Transplant. 25, 849-861.
3. Kapur, R.P., Bigler, S.A., Skelly, M., and Gown, A.M. (1992). Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes. J. Histochem. Cytochem. 40, 207-212.
4. Katagiri, H., Kushida, Y., Nojima, M., Kuroda, Y., Wakao, S., Ishida, K., Endo, F., Kume, K., Takahara, T., Nitta, H., Tsuda, H., Dezawa, M., and Nishizuka, S.S. (2016). A distinct subpopulation of bone marrow mesenchymal stem cells, muse cells, directly commit to the replacement of liver components. Am. J. Transplant. 16, 468-483.
5. Kinoshita, K., Kuno, S., Ishimine, H., Aoi, N., Mineda, K., Kato, H., Doi, K., Kanayama, K., Feng, J., Mashiko, T., Kurisaki, A., and Yoshimura, K. (2015). Therapeutic potential of adiposederived SSEA-3-positive Muse cells for treating diabetic skin ulcers. Stem Cells Transl. Med. 4, 146-155.
6. Kuroda, Y., and Dezawa, M. (2014). Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine. Anat. Rec. (Hoboken). 297, 98-110.
7. Kuroda, Y., Kitada, M., Wakao, S., Nishikawa, K., Tanimura, Y., Makinoshima, H., Goda, M., Akashi, H., Inutsuka, A., Niwa, A., Shigemoto, T., Nabeshima, Y., Nakahata, T., Nabeshima, Y., Fujiyoshi, Y., and Dezawa, M. (2010). Unique multipotent cells in adult human mesenchymal cell populations. Proc. Natl. Acad. Sci. U S A. 107, 8639-8643.
8. Kuroda, Y., Wakao, S., Kitada, M., Murakami, T., Nojima, M., and Dezawa, M. (2013). Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat. Protoc. 8, 1391-1415.
9. Ogura, F., Wakao, S., Kuroda, Y., Tsuchiyama, K., Bagheri, M., Heneidi, S., Chazenbalk, G., Aiba, S., and Dezawa, M. (2014).Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine. Stem Cells Dev. 23, 717-728.
10. Saldanha, K.D., Machado, F.C.D., and Paschoal, F.M. (2012). Action of topical mometasone on the pigmented halos of micrografting in patients with vitiligo. An. Bras. Dermatol. 87, 685-690.
11. Sanclemente, G., Garcia, J.J., Zuleta, J.J., Diehl, C., Correa, C., and Falabella, R. (2008). A double-blind, randomized trial of 0.05%betamethasone vs. topical catalase/dismutase superoxide in vitiligo. J. Eur. Acad. Dermatol. Venereol. 22, 1359-1364.
12. Seiberg, M. (2001). Keratinocyte-melanocyte interactions during melanosome transfer. Pigment Cell Res. 14, 236-242.
13. Simerman, A.A., Dumesic, D.A., and Chazenbalk, G.D. (2014). Pluripotent muse cells derived from human adipose tissue: a new perspective on regenerative medicine and cell therapy. Clin. Transl. Med. 3, 12.
14. Simerman, A.A., Perone, M.J., Gimeno, M.L., Dumesic, D.A., and Chazenbalk, G.D. (2014). A mystery unraveled: nontumorigenic pluripotent stem cells in human adult tissues. Expert Opin. Biol. Ther. 14, 917-929.
15. Sviderskaya, E.V., Easty, D.J., Lawrence, M.A., Sanchez, D.P., Negulyaev, Y.A., Patel, R.H., Anand, P., Korchev, Y.E., and Bennett, D.C. (2009). Functional neurons and melanocytes induced from immortal lines of postnatal neural crest-like stem cells. FASEB J. 23, 3179-3192.
16. Tsuchiyama, K., Wakao, S., Kuroda, Y., Ogura, F., Nojima, M., Sawaya, N., Yamasaki, K., Aiba, S., and Dezawa, M. (2013). Functional melanocytes are readily reprogrammable from multilineage-differentiating stress-enduring (muse) cells, distinct stem cells in human fibroblasts. J. Invest. Dermatol. 133, 2425-2435.
17. Uchida, H., Morita, T., Niizuma, K., Kushida, Y., Kuroda, Y., Wakao, S., Sakata, H., Matsuzaka, Y., Mushiake, H., Tominaga, T., Borlongan, C.V., and Dezawa, M. (2016). Transplantation of unique subpopulation of fibroblasts, muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation. Stem Cells. 34, 160-173.
18. Wakao, S., Akashi, H., Kushida, Y., and Dezawa, M. (2014). Muse cells, newly found non-tumorigenic pluripotent stem cells, reside in human mesenchymal tissues. Pathol. Int. 64, 1-9.
19. Wakao, S., Kitada, M., Kuroda, Y., Shigemoto, T., Matsuse, D., Akashi, H., Tanimura, Y., Tsuchiyama, K., Kikuchi, T., Goda, M., Nakahata, T., Fujiyoshi, Y., and Dezawa, M. (2011). Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc. Natl. Acad. Sci. U S A 108, 9875-9880.
20. Whitton, M.E., Pinart, M., Batchelor, J., Leonardi-Bee, J., Gonzalez, U., Jiyad, Z., Eleftheriadou, V., and Ezzedine, K. (2015). Interventions for vitiligo. Cochrane Database Syst. Rev. 2: CD003263.
21. Yamauchi, T., Kuroda, Y., Morita, T., Shichinohe, H., Houkin, K., Dezawa, M., and Kuroda, S. (2015). Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice. PLoS One 10, e0116009.
22. Yang, R., Jiang, M., Kumar, S.M., Xu, T., Wang, F., Xiang, L., and Xu, X. (2011). Generation of melanocytes from induced pluripotent stem cells. J. Invest. Dermatol. 131, 2458-2466.
23. Yang, Z., Liu, J., Liu, H., Qiu, M., Liu, Q., Zheng, L., Pang, M., Quan, F., and Zhang, Y. (2013). Isolation and characterization of SSEA3(+) stem cells derived from goat skin fibroblasts. Cell Reprogram. 15, 195-205.